Christopher M Counter

13PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 19, 2026
The PAXT connection is a modifier of rare codon-enriched protein expression.

|Jul 14, 2026
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-Driven Alveolar Rhabdomyosarcoma.

|May 28, 2026
Fusion-positive rhabdomyosarcoma oncofusions share a common interactome.

|Jan 20, 2026
KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment.

Rachel A Burge, Ozgun Le Roux, Olesja Popow

|Mar 06, 2025
The essential clathrin adapter protein complex-2 is tumor suppressive specifically in vivo.

Seth P Zimmerman, Lili B DeGraw, Christopher M Counter

|Mar 28, 2024
p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis.

Özgün Le Roux, Jeffery I Everitt, Christopher M Counter

Pageof 3

Frequent Collaborators

3 joint publications

Özgün Le Roux

2 joint publications

Jack F Shern

2 joint publications

Kris C Wood

1 joint publications

M J A Groot Koerkamp